Follow
Amita Puranik
Amita Puranik
PhD Research Scholar
Verified email at nano-medicine.co.in
Title
Cited by
Cited by
Year
Exploring the potential of machine learning for more efficient development and production of biopharmaceuticals
A Puranik, P Dandekar, R Jain
Biotechnology Progress 38 (6), e3291, 2022
172022
Development and optimization of a LC-MS based multi-attribute method (MAM) workflow for characterization of therapeutic Fc-fusion protein
A Puranik, P Rasam, P Dandekar, R Jain
Analytical Biochemistry 660, 114969, 2023
82023
Formulation of therapeutic proteins: strategies for developing oral protein formulations
S Patil, A Narvekar, A Puranik, R Jain, P Dandekar
Innovative dosage forms: design and development at early stage, 391-432, 2019
72019
Mass spectrometry‐based glycoprofiling of biopharmaceuticals by using an automated data processing tool: SimGlycan®
A Puranik, R Goswami, P Sutar, D Tupe, P Rasam, P Dandekar, R Jain
Journal of Separation Science 46 (3), 2200521, 2023
12023
Characterization of outcomes of amino acid modifications using a combinatorial approach to reveal physical and structural perturbations: A case study using trastuzumab biosimilar
R Kamble, A Puranik, A Narvekar, P Dandekar, R Jain
Journal of Chromatography B 1209, 123430, 2022
12022
A comparison between analytical approaches for molecular weight estimation of proteins with variable levels of glycosylation
A Puranik, M Saldanha, P Dandekar, R Jain
Electrophoresis 43 (11), 1223-1232, 2022
12022
Large-Scale Purification and Characterization of Recombinant Receptor-Binding Domain (RBD) of SARS-CoV-2 Spike Protein Expressed in Yeast
G Nagar, S Jain, M Rajurkar, R Lothe, H Rao, S Majumdar, M Gautam, ...
Vaccines 11 (10), 1602, 2023
2023
FcγRIIIA affinity chromatography complements conventional functional characterization of rituximab
A Narvekar, A Puranik, B Kulkarni, D Jagtap, R Jain, P Dandekar
Biotechnology Progress 39 (1), e3304, 2023
2023
Advanced strategies in glycosylation prediction and control during biopharmaceutical development: Avenues toward industry 4.0
A Puranik, M Saldanha, N Chirmule, P Dandekar, R Jain
Biotechnology Progress 38 (5), e3283, 2022
2022
Cancer of Reproductive System: Receptors and Targeting Strategies
M Gore, A Puranik, A Indurkar, B Sonowal, PV Devarajan, R Jain, ...
Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis, 109-140, 2019
2019
Demystifying the Potential Applications of Blockchain Technology in Pharma and Biopharma Industry
A Puranik, P Dandekar, R Jain
The system can't perform the operation now. Try again later.
Articles 1–11